We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
+12.61%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.57B
AUM Growth
-$99.9M
Cap. Flow
-$270M
Cap. Flow %
-17.18%
Top 10 Hldgs %
52.85%
Holding
344
New
45
Increased
88
Reduced
69
Closed
37

Top Buys

Rank Stock Value
1
BZUN
Baozun
BZUN
+$17.1M
2
MOMO
Hello Group
MOMO
+$5.31M
3
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
+$4.25M
4
BMY icon
Bristol-Myers Squibb
BMY
+$4.13M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$3.26M

Top Sells

Rank Stock Value
1
KANG
iKang Healthcare Group, Inc.
KANG
+$94.3M
2
VIPS icon
Vipshop
VIPS
+$47.3M
3
DBRG icon
DigitalBridge
DBRG
+$39.3M
4
BKD icon
Brookdale Senior Living
BKD
+$37.8M
5
CRTO icon
Criteo
CRTO
+$15.3M

Sector Composition

Rank Sector Weight
1 Healthcare 37.62%
2 Financials 6.46%
3 Consumer Discretionary 4.13%
4 Industrials 2.9%
5 Communication Services 2.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCD icon
101
McDonald's
MCD
$193B
$1.79M 0.11%
9,450
+4,900
+108% +$889K
ATRS
102
DELISTED
Antares Pharma, Inc.
ATRS
$1.77M 0.11%
591,708
+52,108
+10% +$169K
LIN icon
103
Linde
LIN
$236B
$1.75M 0.11%
10,168
+4,994
+97% +$830K
WM icon
104
Waste Management
WM
$95B
$1.72M 0.11%
16,630
+1,030
+7% +$101K
CB icon
105
Chubb
CB
$140B
$1.7M 0.11%
12,231
+1,250
+11% +$166K
CL icon
106
Colgate-Palmolive
CL
$74.8B
$1.68M 0.11%
24,950
+19,150
+330% +$1.24M
NKE icon
107
Nike
NKE
$64.1B
$1.64M 0.1%
19,567
-1,760
-8% -$145K
ADMS
108
DELISTED
Adamas Pharmaceuticals
ADMS
$1.61M 0.1%
223,959
+27,000
+14% +$243K
NBRV
109
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$1.59M 0.1%
+2,666
New +$1.45M
ACAD icon
110
Acadia Pharmaceuticals
ACAD
$4.51B
$1.57M 0.1%
59,000
-116,000
-66% -$2.71M
AXP icon
111
American Express
AXP
$224B
$1.57M 0.1%
14,355
+9,100
+173% +$956K
HRTX icon
112
Heron Therapeutics
HRTX
$93.4M
$1.54M 0.1%
65,557
– –
MRNS
113
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.54M 0.1%
97,715
-25,284
-21% -$364K
BRK.A icon
114
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.5M 0.1%
5
-1
-17% -$303K
BX icon
115
Blackstone
BX
$104B
$1.5M 0.1%
+43,250
New +$1.44M
LLY icon
116
Eli Lilly
LLY
$1.08T
$1.48M 0.09%
11,445
-3,215
-22% -$391K
B
117
Barrick Mining
B
$60.9B
$1.43M 0.09%
103,000
+63,000
+158% +$814K
TSM icon
118
TSMC
TSM
$1.94T
$1.42M 0.09%
35,120
-13,000
-27% -$496K
SYRE icon
119
Spyre Therapeutics
SYRE
$8.5B
$1.4M 0.09%
7,046
+3,160
+81% +$659K
VEON icon
120
VEON
VEON
$3.5B
$1.38M 0.09%
26,424
– –
VBIV
121
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$1.37M 0.09%
24,403
+2,900
+13% +$157K
MGNX icon
122
MacroGenics
MGNX
$233M
$1.36M 0.09%
77,573
+11,111
+17% +$192K
JPM icon
123
JPMorgan Chase
JPM
$916B
$1.34M 0.09%
13,324
-11,686
-47% -$1.2M
COWN
124
DELISTED
Cowen Inc. Class A Common Stock
COWN
$1.34M 0.08%
92,221
-429,940
-82% -$6.57M
TVTX icon
125
Travere Therapeutics
TVTX
$5.17B
$1.31M 0.08%
56,837
– –
3 4
5
6 7

Similar funds

NC
NovaPoint Capital Atlanta, Georgia $399M AUM 26.97% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
IAA
Ironsides Asset Advisors Rocky Mount, North Carolina $399M AUM 13.99% 1-Year Est. Return
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return

Fosun International's Q1 2019 Portfolio in Review

As of Q1 2019, Fosun International held 344 positions worth $1.57B, down 6% from $1.67B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Fosun International withdrew a net $270M in Q1 2019, closing 37 positions and reducing 69 holdings. Its most notable exit was iKang Healthcare Group, Inc., an estimated $94.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 39% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Fosun International opened a new position in Baozun worth $20.3M.

  • Fosun International's largest Q1 2019 buy was Baozun: 488,992 shares worth $20.3M.
  • Fosun International added most to Neurocrine Biosciences in Q1 2019, an estimated $3.26M increase.
  • Fosun International's biggest Q1 2019 reduction was Vipshop, cutting an estimated $47.3M.
  • Fosun International fully exited iKang Healthcare Group, Inc. in Q1 2019, selling an estimated $94.3M.
  • Fosun International's ten largest holdings make up 53% of its $1.57B portfolio in Q1 2019.
  • Fosun International opened 45 new positions and closed 37 in Q1 2019.
  • Fosun International's portfolio value fell 6% quarter-over-quarter to $1.57B.

Based on Fosun International's 13F filing for Q1 2019, filed 10 May 2019.